Skip to content
Advertisement

FILE - This May 27, 2013, file photo, shows the head office and logo of Valeant Pharmaceuticals in Laval, Quebec, Canada.  Valeant is selling its CeraVe, AcneFree and AMBI skincare brands to L'Oréal for $1.3 billion. Shares of the pharmaceutical company soared more than 13 percent in Tuesday, Jan. 10, 2017,  premarket trading.(Ryan Remiorz/The Canadian Press via AP, File)

FILE - This May 27, 2013, file photo, shows the head office and logo of Valeant Pharmaceuticals in Laval, Quebec, Canada. Valeant is selling its CeraVe, AcneFree and AMBI skincare brands to L'Oréal for $1.3 billion. Shares of the pharmaceutical company soared more than 13 percent in Tuesday, Jan. 10, 2017, premarket trading.(Ryan Remiorz/The Canadian Press via AP, File)

Featured Photo Galleries